Clicky

Arcutis Biotherapeutics, Inc.(ARQT)

Description: Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.


Keywords: Organ Systems Immunology Autoimmune Disease Psoriasis Atopic Dermatitis Dermatitis Plaque Psoriasis Eczema Alopecia Areata Dermatological Diseases Type I Hypersensitivity Vitiligo Atopy

Home Page: www.arcutis.com

ARQT Technical Analysis

3027 Townsgate Road
Westlake Village, CA 91361
United States
Phone: 805 418 5006


Officers

Name Title
Mr. Todd Franklin Watanabe M.A. Pres, CEO & Director
Dr. Bhaskar Chaudhuri Ph.D. Co-Founder & Independent Director
Mr. Scott L. Burrows CFO & Principal Accounting Officer
Dr. David W. Osborne Ph.D. Chief Technical Officer
Dr. Patrick E. Burnett M.D., Ph.D. Sr. VP & Chief Medical Officer
Mr. Matthew Richard Moore Sr. VP & Chief Bus. Officer
Ms. Patricia A. Turney Sr. VP of Operations
Mr. Eric McIntyre Head of Investor Relations
Ms. Courtney Barton VP and Chief Compliance Officer & Privacy Officer
Mr. Masaru Matsuda Esq., J.D. Sr. VP, Gen. Counsel & Corp. Sec.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.742
Price-to-Sales TTM: 1385.7922
IPO Date: 2020-01-31
Fiscal Year End: December
Full Time Employees: 147
Back to stocks